Infliximab Treatment for Refractory Kawasaki Disease in Korean Children

BACKGROUND AND OBJECTIVES: This was a multicenter study to evaluate the usefulness of the tumor necrosis factor-alpha (TNF-α) blocker infliximab for treatment of Korean pediatric patients with refractory Kawasaki disease (KD). SUBJECTS AND METHODS: Data from 16 patients throughout Korea who were dia...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Min Seob, Lee, Sang Bum, Sohn, Sejung, Oh, Jin Hee, Yoon, Kyung Lim, Han, Ji Whan, Kim, Chul Ho
Formato: Texto
Lenguaje:English
Publicado: The Korean Society of Cardiology 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910290/
https://www.ncbi.nlm.nih.gov/pubmed/20664742
http://dx.doi.org/10.4070/kcj.2010.40.7.334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910290/
https://www.ncbi.nlm.nih.gov/pubmed/20664742
http://dx.doi.org/10.4070/kcj.2010.40.7.334

Ejemplares similares